Regeneron begins clinical trials for COVID-19 antibody treatment
Regeneron Pharmaceuticals has started its first clinical trial investigating an antibody treatment for COVID-19. Read More
Manufacturers adapt technologies for hand sanitizers during COVID-19
Changes to manufacturing processes have emerged to meet the demand of certain products during the COVID-19 pandemic, including hand sanitizer. The chemical composition of hand sanitizer is carefully regulated, and analytical techniques are now being repurposed to assist in rapid production efforts. Read More
NIH researchers investigate virulence of SARS-CoV-2 virus
What makes the SARS-CoV-2 virus so virulent? Researchers from the U.S. National Institutes of Health (NIH) analyzed the genomics of the virus -- and compared it to other coronaviruses -- in a June 10 article in the Proceedings of the National Academy of Sciences. Read More
Oblique Therapeutics identifies epitope for SARS-CoV-2 antibodies
Oblique Therapeutics has used its Abiprot antibody discovery platform to identify an epitope in SARS-CoV-2 that may facilitate the generation of new neutralizing antibodies to treat COVID-19. Read More
Grifols begins production of COVID-19 immunotherapy
Grifols will start production of anti-SARS-CoV-2 hyperimmune immunoglobulin with specific antibodies using plasma from patients who have recovered from COVID-19. Read More
Moderna moves COVID-19 vaccine to late-stage clinical trial
Moderna has finalized phase III clinical study protocols for its mRNA-1273 COVID-19 vaccine candidate in coordination with the U.S. Food and Drug Administration and expects the study to begin in July. Read More
How will summer weather shape the spread of COVID-19?
New research shows that while higher temperatures and humidity can slow the spread of COVID-19, longer hours of sunlight are associated with a higher incidence of the disease. Human behavior may be at the root of this quandary, according to a June 8 Geographical Analysis publication. Read More
J&J to start clinical trial for COVID-19 vaccine in July
Johnson & Johnson is accelerating its investigational SARS-CoV-2 vaccine candidate, Ad26.COV2-S, recombinant, with the initiation of a phase I/IIA clinical trial in late July. Read More
Panacea, Refana collaborate on COVID-19 vaccine
Panacea Biotec and Refana are partnering on an inactivated virus-based vaccine for COVID-19 through a joint venture company that will be based in Ireland. Read More
FDA researchers explore vaccine responses to SARS-CoV-2 antigens
Different proteins associated with SARS-CoV-2, the virus that causes COVID-19, generate unique immune responses when given to rabbits as immunizations, according to a June 8 Science Translational Medicine article. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter